» Articles » PMID: 28678776

Crystal Structures of Agonist-bound Human Cannabinoid Receptor CB

Abstract

The cannabinoid receptor 1 (CB) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ-tetrahydrocannabinol (Δ-THC). Here we report two agonist-bound crystal structures of human CB in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resolution, respectively. The two CB-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region. In addition, a 'twin toggle switch' of Phe200 and Trp356 (superscripts denote Ballesteros-Weinstein numbering) is experimentally observed and appears to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB and provide a molecular basis for predicting the binding modes of Δ-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB seems to be a common feature among certain class A G-protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.

Citing Articles

Virtual library docking for cannabinoid-1 receptor agonists with reduced side effects.

Tummino T, Iliopoulos-Tsoutsouvas C, Braz J, OBrien E, Stein R, Craik V Nat Commun. 2025; 16(1):2237.

PMID: 40044644 PMC: 11882969. DOI: 10.1038/s41467-025-57136-7.


Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery.

Shen S, Wu C, Yang Z, Wang K, Shao Z, Yan W Acta Pharmacol Sin. 2025; .

PMID: 39910211 DOI: 10.1038/s41401-024-01472-9.


Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.

Kumar U Int J Mol Sci. 2025; 26(1.

PMID: 39796008 PMC: 11720483. DOI: 10.3390/ijms26010152.


Structural basis of THC analog activity at the Cannabinoid 1 receptor.

Thorsen T, Kulkarni Y, Sykes D, Boggild A, Drace T, Hompluem P Nat Commun. 2025; 16(1):486.

PMID: 39779700 PMC: 11711184. DOI: 10.1038/s41467-024-55808-4.


Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.

Conflitti P, Lyman E, Sansom M, Hildebrand P, Gutierrez-de-Teran H, Carloni P Nat Rev Drug Discov. 2025; .

PMID: 39747671 DOI: 10.1038/s41573-024-01083-3.


References
1.
Feigenbaum J, Bergmann F, Richmond S, Mechoulam R, Nadler V, Kloog Y . Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci U S A. 1989; 86(23):9584-7. PMC: 298542. DOI: 10.1073/pnas.86.23.9584. View

2.
Skjaerven L, Yao X, Scarabelli G, Grant B . Integrating protein structural dynamics and evolutionary analysis with Bio3D. BMC Bioinformatics. 2014; 15:399. PMC: 4279791. DOI: 10.1186/s12859-014-0399-6. View

3.
DAntona A, Ahn K, Kendall D . Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry. 2006; 45(17):5606-17. PMC: 2667143. DOI: 10.1021/bi060067k. View

4.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

5.
Friesner R, Murphy R, Repasky M, Frye L, Greenwood J, Halgren T . Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006; 49(21):6177-96. DOI: 10.1021/jm051256o. View